a year ago
SANA
AnalystsEmily BodnarEmily Bodnar's Stock Forecasts
AnalystsEmily Bodnar
Sectors:
Analyst Ranking
Bottom 5%
#4953 out of 5160 analysts
Average Return
-2.06%
Win Rate
30%95 out of 318
Risk vs Reward
Poor
Good
Emily Bodnar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Olema Pharmaceuticals IncOLMA | +567.88% | $4.11 | $27.45 | 2025-03-19 - 2025-12-24 | Buy |
Olema Pharmaceuticals IncOLMA | +544.37% | $4.26 | $27.45 | 2025-03-05 - 2025-12-24 | Buy |
Olema Pharmaceuticals IncOLMA | +533.95% | $4.33 | $27.45 | 2025-03-11 - 2025-12-24 | Buy |
Olema Pharmaceuticals IncOLMA | +461.35% | $4.89 | $27.45 | 2025-04-28 - 2025-12-24 | Buy |
Rapt Therapeutics IncRAPT | +422.07% | $6.87 | $35.84 | 2025-05-22 - 2025-12-24 | Buy |
Emily Bodnar Analyst Color
Get additional color on Emily Bodnar's coverage of popular stocks
2 years ago
FEMY
Emily Bodnar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vtv Therapeutics IncVTVT | 3 | Buy | $47.00 | +26.99% | Maintains | 7 days ago |
Arcus Biosciences IncRCUS | 7 | Buy | $32.00 | +38.41% | Maintains | 14 days ago |
Olema Pharmaceuticals IncOLMA | 22 | Buy | $45.00 | +63.93% | Maintains | 15 days ago |
Acrivon Therapeutics IncACRV | 12 | Buy | $19.00 | +694.98% | Reiterates | a month ago |
Anaptysbio IncANAB | 12 | Buy | $51.00 | +1.98% | Maintains | a month ago |
Agios Pharmaceuticals IncAGIO | 3 | Buy | $48.00 | +64.55% | Maintains | a month ago |
Artiva Biotherapeutics IncARTV | 2 | Buy | $15.00 | +248.84% | Maintains | a month ago |
Sana Biotechnology IncSANA | 11 | Buy | $9.00 | +98.68% | Maintains | 2 months ago |
Context Therapeutics IncCNTX | 11 | Buy | $5.00 | +334.78% | Maintains | 2 months ago |
Ventyx Biosciences IncVTYX | 14 | Buy | $18.00 | +96.08% | Upgrades | 2 months ago |
Novocure LtdNVCR | 19 | Buy | $42.00 | +212.50% | Maintains | 2 months ago |
Rapt Therapeutics IncRAPT | 3 | Buy | $72.00 | +100.89% | Maintains | 2 months ago |
Senti Biosciences IncSNTI | 1 | Buy | $12.00 | +943.48% | Initiates Coverage On | 2 months ago |
Tg Therapeutics IncTGTX | 1 | Buy | $60.00 | +93.11% | Assumes | 3 months ago |
Agenus IncAGEN | 14 | Buy | $23.00 | +586.57% | Reiterates | 4 months ago |
Briacell Therapeutics CorpBCTX | 15 | Buy | $40.00 | +394.44% | Maintains | 4 months ago |
Mink Therapeutics IncINKT | 14 | Buy | $35.00 | +194.12% | Upgrades | 4 months ago |
Femasys IncFEMY | 25 | Buy | $8.00 | +998.90% | Maintains | 4 months ago |
Sab Biotherapeutics IncSABS | 2 | Buy | $9.00 | +134.38% | Maintains | 5 months ago |
Jasper Therapeutics IncJSPR | 10 | Buy | $20.00 | +992.90% | Maintains | 6 months ago |
Nextcure IncNXTC | 9 | Buy | $36.00 | +181.47% | Reiterates | 6 months ago |
Arcellx IncACLX | 13 | Buy | $115.00 | +74.24% | Reiterates | 6 months ago |
Transcode Therapeutics IncRNAZ | 17 | Buy | $280.00 | +3,668.51% | Maintains | 8 months ago |
Connect Biopharma Holdings LtdCNTB | 6 | Buy | $8.00 | +193.04% | Reiterates | 9 months ago |
Io Biotech IncIOBT | 13 | Buy | $12.00 | +1,523.82% | Reiterates | 9 months ago |
Genelux CorpGNLX | 7 | Buy | $30.00 | +581.82% | Reiterates | 9 months ago |
Nkarta IncNKTX | 13 | Buy | $18.00 | +894.48% | Reiterates | 9 months ago |
Imunon IncIMNN | 13 | Buy | $210.00 | +6,244.41% | Reiterates | 9 months ago |
Atossa Therapeutics IncATOS | 13 | Buy | $7.00 | +920.41% | Reiterates | 9 months ago |
Tenaya Therapeutics IncTNYA | 1 | Buy | $18.00 | +2,316.11% | Reiterates | a year ago |
Acelyrin IncSLRN | 13 | Hold | $6.00 | +164.32% | Maintains | a year ago |
Geron CorpGERN | 3 | Buy | $9.00 | N/A | Reiterates | a year ago |
Purple Biotech LtdPPBT | 13 | Buy | $33.00 | N/A | Reiterates | a year ago |
Gracell Biotechnologies IncGRCL | 6 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Dice Therapeutics IncDICE | 8 | Hold | $48.00 | N/A | Reiterates | 2 years ago |
Sqz Biotechnologies CoSQZB | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.